-
-
-
-
-
-
-
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
66,607 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

